Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients
Conclusion: In our experience, the cardiovascular polypill achieved a higher reduction in SBP levels and was well tolerated. Adherence was similar to that found in the previous literature, which is remarkable given the real-life setting of our study.Cerebrovasc Dis Extra 2020;10:166 –173
Source: Cerebrovascular Diseases Extra - Category: Neurology Source Type: research
More News: Aspirin | Atorvastatin Calcium | Cardiology | Cardiovascular | Cholesterol | Heart | Ischemic Stroke | Lipitor | Neurology | Statin Therapy | Stroke | Study | Zivast